Change Country
Welcome to Netherlands
Please read the important information below before continuing to our website

Please read the important information below before continuing to our website.  

To enter the website, please confirm that you have read and understood the important information that is contained below by clicking "I Accept" at the bottom of this page.


This website is published by Lyxor International Asset Management (LIAM), a French asset management company approved by the Autorité des Marchés Financiers (the French Financial Markets Authority) (AMF) (17 place de la Bourse 75082 Paris Cedex 02) under the UCITS (2009/65/EC) and AIFM (2011/31/EU) directives. LIAM is registered in the Netherlands in the public register of the Netherlands Authority for the Financial Markets (Autoriteit Financiële Markten) as a manager (beheerder) of a UCITS.

The website is hosted on Microsoft Azure servers.

This website is subject to French and Dutch law.


A professional investor is a professional investor (professionele belegger) within the meaning of the Act on the Financial Supervision (Wet op het financieel toezicht) (AFS).

A professional investor within the meaning of the AFS is one of the following:

  • a bank
  • a collective investment scheme (UCITS or AIF) and a management company of such scheme
  • a pension fund and management company of such fund
  • an investment firm
  • a national or regional governments, public bodies, central bank, international or supranational financial organisation or other type of international organisation
  • a market maker
  • a local: party trading only for its own account or providing quotes for trades in derivatives
  • an insurance company
  • a financial institution
  • commodity and commodity derivatives dealers
  • institutional investors whose main activity is to invest in financial instruments, including entities dedicated to the securitisation of assets or other financing transactions
  • large undertakings meeting two of the following size requirements on a company basis (a) balance sheet total of EUR 20,000,000, (b) net turnover of EUR 40,000,000 and (c) own funds of € 2,000,000


Please note that the above summary is provided for information purposes only. If you are uncertain as to whether you can be classified as a professional investor within the meaning of the AFS then you should seek independent advice.


Marketing Restrictions and Implications


Lyxor UCITS compliant Exchange Traded Funds (Lyxor UCITS ETFs) referred to on this website are open ended mutual investment funds (i) established under the French law and approved by the Autorité des Marchés Financiers (the French Financial Markets Authority), or (ii) established under the Luxembourg law and approved by the Commission de Surveillance du Secteur Financier (the Luxembourg Financial Supervisory Committee). Most, if not all, of the protections provided by the Dutch regulatory system generally and for funds authorised in the Netherlands do not apply to these exchange traded funds (ETFs). In particular, investors should note that holdings in this product will not be covered by the provisions of the UK Financial Services Compensation Scheme, the Dutch Investor Compensation Scheme (beleggerscompensatiestelsel) or by any similar scheme.


This website is exclusively intended for persons who are not "US persons", as such term is defined in Regulation S or the US Securities Act 1933, as amended, and who are not physically present in the US. This website does not constitute an offer or an invitation to purchase any securities in the United States or in any other jurisdiction in which such offer or invitation is not authorised or to any person to whom it is unlawful to make such offer or solicitation. Potential users of this website are requested to inform themselves about and to observe any such restrictions.


Index Replication Process


Lyxor UCITS ETFs follow both physical and synthetic index replication process.


However, most Lyxor UCITS ETFs follow synthetic replication process. This consists of entering into a derivative transaction (a ‘Performance Swap’, as defined below) with a counterparty that provides complete and effective exposure to its benchmark index. Lyxor has adopted this methodology in order to minimise tracking error, optimise transaction costs and reduce operational risks.


A Performance Swap is a contractual agreement which is negotiated over-the-counter (OTC) between two parties: the Lyxor UCITS ETF and its counterparty. From a risk perspective, each Performance Swap ranks equally with other senior unsecured obligations of the counterparty, such as common bonds (i.e., same rights to payments). In the Performance Swap, the counterparty of the Lyxor UCITS ETF commits to pay the Lyxor UCITS ETF a variable return based on a pre-determined benchmark index, instead of a fixed stream of income (as in bonds). At the same time, the counterparty will receive from the Lyxor UCITS ETF the performance and any related revenues generated by the basket's assets (excluding the value of the Performance Swap) held by the Lyxor UCITS ETF. Information provided on individual ETFs includes data on the basket relating to the ETF and the percentage value of the basket represented by each asset. The information is relevant to the closing values on the date given. 


Investment Risks


The Lyxor UCITS ETFs described on this website are not suitable for everyone. Investors' capital is at risk. Investors should not deal in this product unless they understand, having obtained independent professional advice where necessary, its nature, terms and conditions, and the extent of their exposure to risk. The value of the product can go down as well as up and can be subject to volatility due to factors such as price changes in the underlying instrument and interest rates. If a fund is quoted in a different currency to the index, currency risks exist.


Prior to any investment in any Lyxor UCITS ETF, you should make your own appraisal of the risks from a financial, legal and tax perspective, without relying exclusively on the information provided by us. We recommend that you consult your own independent professional advisors (including legal, tax, financial or accounting advisors, as appropriate).


Specific Risks


·         Capital at Risk. ETFs are tracking instruments: Their risk profile is similar to a direct investment in the Benchmark Index. Investors’ capital is fully at risk and investors may not get back the amount originally invested. Investments are not covered by the provisions of the UK Financial Services Compensation Scheme, the Dutch Investor Compensation Scheme (beleggerscompensatiestelsel) or by any similar scheme.

·         Counterparty Risk. Investors may be exposed to risks resulting from the use of an OTC Swap with Societe Generale. Physical ETFs may have Counterparty Risk resulting from the use of a Securities Lending Programme.

·         Currency Risk. ETFs may be exposed to currency risk if the ETF or Benchmark Index holdings are denominated in a currency different to that of the Benchmark Index they are tracking. This means that exchange rate fluctuations could have a negative or positive effect on returns.

·         Replication Risk. ETFs are designed to replicate the performance of the Benchmark Index. Unexpected events relating to the constituents of the Benchmark Index may impact the Index provider’s ability to calculate the Benchmark Index, which may affect the ETF’s ability to replicate the Benchmark Index efficiently. This may create Tracking Error in the ETF.

·         Underlying Risk. The Benchmark Index of a Lyxor ETF may be complex and volatile. When investing in commodities, the Benchmark Index is calculated with reference to commodity futures contracts which can expose investors to risks related to the cost of carry and transportation. ETFs exposed to Emerging Markets carry a greater risk of potential loss than investment in Developed Markets as they are exposed to a wide range of unpredictable Emerging Market risks.

·         Liquidity Risk. On-exchange liquidity may be limited as a result of a suspension in the underlying market represented by the Benchmark Index tracked by the ETF; a failure in the systems of one of the relevant stock exchanges, Societe Generale or other Market Maker systems; or an abnormal trading situation or event. 

The securities can be neither offered in nor transferred to the United States.




Any statement in relation to tax, where made, is generic and non-exhaustive and is based on our understanding of the laws and practice in force as of the date of this document and is subject to any changes in law and practice and the interpretation and application thereof, which changes could be made with retroactive effect. Any such statement must not be construed as tax advice and must not be relied upon. The tax treatment of investments will, inter alia, depend on an individual’s circumstances. Investors must consult with an appropriate professional tax adviser to ascertain for themselves the taxation consequences of acquiring, holding and/or disposing of any investments mentioned on this website. 

Further information on the risk factors are available in the [Risk Warning – link to risk page] section of the website.


Any fund prospectus and supplements are available at Information given about the past performance of the funds is no guarantee of future performance. No investment decision should be taken without reading the fund prospectus and any fund supplement of the fund concerned.


Although the content of the website is based upon information that LIAM consider reliable or comes from sources that LIAM consider reliable, LIAM have not verified such information. Lyxor make no representation or warranty as to the accuracy, completeness or adequacy of any information.  Any reproduction, disclosure or dissemination of the materials available on the website is prohibited.



This website uses cookies to make the website work or improve your user experience. Cookies are small text files that are saved on your computer or device, which are used for several purposes such as detecting preferences and improving site navigation. By continuing to use this website you consent for cookies to be used. For more details, including how to amend your preferences, please read our [Privacy and Cookies Policy] link to privacy & cookie page.

By clicking "I Confirm" to the Terms of this website and accessing the information on the website, you shall be deemed to have represented to us that you are not a U.S. person and that you are not located in the United States of America, its territories and possessions, and any State of the United States of America and that you are authorised to receive the information to and on this website.




By continuing to browse the site, you are agree on the use of cookies to track the number of visits.To know more about cookies policy:click here

Lyxor ETFs - Download Center | Lyxor Netherlands


Legal Documents

Factsheets (204)
Prospectus (203)
KIID (198)
Annual Reports (188)
Semi-Annual Reports (165)
Notice to Shareholders (13)
Cotation Document ()
UKRFS Reports ()
Notice to Shareholders ()
Notice to shareholders ()
Tax data ()
Statutes ()
Lyxor BofAML $ Short Term High Yield Bond UCITS ETF ()
Social media ()
UK Tax Report ()

Lyxor Publications

Press Releases (17)
Brochures ()
Funds Holdings ()
Lyxor ETF Range ()
Latest Dividends ()
Dividends ()
Investor notices ()
Customer magazine ()
Lyxor ETF Product Range ()
Taxation ()
Replication information ()
Press Releases ()
Product Range ()
Information about UE regulation N. 236/2012 ()
Educational fact sheets & brochures ()
Academic papers ()
ETF documents ()
Media articles (5)
Lyxor ETF Barometer ()
Educational factsheets (2)
Marketing Documents ()
CBI Green Bonds Methodology (1)
Solactive Index Guidelines (1)
Climate Bonds Standard (1)

ETF Publications

Weekly news (14)
ETF trends (50)
Whitepaper (10)
Smart Beta ()
Brochures ()
Research ()
Investment Ideas ()
Blog ()

Search result :

204 results
ETF NameISINTypeLanguagePublication DateSizeDownload
MR-Lyxor MSCI Russia UCITS ETF - AccFR0010326140FactsheetsEnglish05 Dec 2018245 Ko
MR-Lyxor MSCI Brazil UCITS ETF - AccFR0010408799FactsheetsEnglish05 Dec 2018251 Ko
MR-Lyxor MSCI South Africa UCITS ETF - AccFR0010464446FactsheetsEnglish05 Dec 2018264 Ko
MR-Lyxor CAC 40 (DR) UCITS ETF - DistFR0007052782FactsheetsEnglish30 Nov 2018261 Ko
MR-Lyxor EURO STOXX 50 (DR) UCITS ETF - DistFR0007054358FactsheetsEnglish30 Nov 2018274 Ko
MR-Lyxor Dow Jones Industrial Average UCITS ETF - DistFR0007056841FactsheetsEnglish30 Nov 2018256 Ko
MR-Lyxor NASDAQ-100 UCITS ETFFR0007063177FactsheetsEnglish30 Nov 2018261 Ko
MR-Lyxor FTSE MIB UCITS ETF - DistFR0010010827FactsheetsEnglish30 Nov 2018263 Ko
MR-Lyxor China Enterprise (HSCEI) UCITS ETF - AccFR0010204081FactsheetsEnglish30 Nov 2018257 Ko
MR-Lyxor Japan (TOPIX) (DR) UCITS ETF - Dist EURFR0010245514FactsheetsEnglish30 Nov 2018259 Ko
MR-Lyxor IBEX 35 (DR) UCITS ETF - DistFR0010251744FactsheetsEnglish30 Nov 2018260 Ko
MR-Lyxor MSCI Europe UCITS ETF - DistFR0010261198FactsheetsEnglish30 Nov 2018272 Ko
MR-Lyxor Commodities Thomson Reuters/CoreCommodity CRB TR UCITS ETF - AccFR0010270033FactsheetsEnglish30 Nov 2018234 Ko
MR-Lyxor MSCI USA UCITS ETF - DistFR0010296061FactsheetsEnglish30 Nov 2018276 Ko
MR-Lyxor MSCI AC Asia Pacific Ex Japan UCITS ETF - AccFR0010312124FactsheetsEnglish30 Nov 2018275 Ko
MR-Lyxor MSCI World UCITS ETF - DistFR0010315770FactsheetsEnglish30 Nov 2018280 Ko
MR-Lyxor MSCI Turkey UCITS ETF - AccFR0010326256FactsheetsEnglish30 Nov 2018248 Ko
MR-Lyxor STOXX Europe 600 Automobiles & Parts UCITS ETF - AccFR0010344630FactsheetsEnglish30 Nov 2018240 Ko
MR-Lyxor STOXX Europe 600 Technology UCITS ETF - AccFR0010344796FactsheetsEnglish30 Nov 2018255 Ko
MR-Lyxor STOXX Europe 600 Telecommunications UCITS ETF - AccFR0010344812FactsheetsEnglish30 Nov 2018248 Ko
MR-Lyxor STOXX Europe 600 Travel & Leisure UCITS ETF - AccFR0010344838FactsheetsEnglish30 Nov 2018248 Ko
MR-Lyxor STOXX Europe 600 Utilities UCITS ETF - AccFR0010344853FactsheetsEnglish30 Nov 2018246 Ko
MR-Lyxor STOXX Europe 600 FOOD & BEVERAGE UCITS ETF - AccFR0010344861FactsheetsEnglish30 Nov 2018249 Ko
MR-Lyxor STOXX Europe 600 Healthcare UCITS ETF - AccFR0010344879FactsheetsEnglish30 Nov 2018250 Ko
MR-Lyxor STOXX Europe 600 Industrial Goods & Services UCITS ETF - AccFR0010344887FactsheetsEnglish30 Nov 2018257 Ko